Expression of HMGB1 and NF-κB in Fetal Membranes of Premature Rupture of Membranes
DOI:
https://doi.org/10.15850/amj.v10n4.2911Keywords:
fetal membranes, HMGB1, NF-κB, premature rupture of membranesAbstract
Background: Inflammation, either sterile or infection-related, may lead to premature rupture of membranes (PROM). The non-histone nuclear proteins, high mobility group box-1 (HMGB1), and nuclear factor kappa-B (NF-κB) transcription factors have been extensively investigated in many disorders involving inflammatory reactions. This study aimed to determine the expression of HMGB1 and NF-κB in fetal membranes of PROM compared with non-PROM.
Methods: This study was an analytical observational study with a case-control design, performed from November 2021 to January 2022, including 40 fetal membrane samples (20 PROM and 20 non-PROM), which were obtained from pregnant women treated in the emergency unit of a hospital in Surabaya from August to November 2019 using the non-probability sampling method. The HMGB1 and NF-κB expressions were examined using the immunohistochemical method and further viewed under a light microscope (400x magnification), then assessed by Image-J software. The values were then compared between PROM and non-PROM, and analyzed using the Mann-Whitney U test.
Results: There was a significant difference (p<0.001) in the expression of HMGB1 and NF-κB in PROM and non-PROM for HMGB1 45.86± 14.21% vs. 8.50± 5.66% expression/mm2; and NF-κB 33.47±5.45% vs. 7.29±4.90% expression/mm2, respectively.
Conclusions: PROM groups have significantly higher expression of HMGB1 and NF-κB s, indicating their higher activity and contribution to PROM.
References
- World Health Organization. New global estimates on preterm birth published [Internet]. Geneva:WHO. 2018 [cited 2022 July 5]. Available from: https://www.who.int/news/item/17-11-2018-new-global-estimates-on-preterm-birth-published.
- Halimi Asl AA, Safari S, Parvareshi Hamrah M. Epidemiology and related risk factors of preterm labor as an obstetrics emergency. Emerg (Tehran). 2017;5(1):e3.
- Assefa NE, Berhe H, Girma F, Berhe K, Berhe YZ, Gebrehet G, et al. Risk factors of premature rupture of membranes in public hospitals at Mekele city, Tigray, a case control study. BMC Pregnancy Childbirth. 2018;18(1):386.
- Verbruggen SW, Oyen ML, Phillips ATM, Nowlan NC. Function and failure of the fetal membrane: modelling the mechanics of the chorion and amnion. PLoS One. 2017;12(3):e0171588.
- Nunes V, Cross J, Speich JE, Morgan DR, Strauss JF 3rd, Ramus RM. Fetal membrane imaging and the prediction of preterm birth: a systematic review, current issues, and future directions. BMC Pregnancy Childbirth. 2016;16(1):387.
- Lee S-A, Kwak MS, Kim S, Shin J-S. The role of high mobility group box 1 in innate immunity. Yonsei Med J. 2014;55(5):1165–76.
- Yang H, Wang H, Andersson U. Targeting inflammation driven by HMGB1. Front Immunol. 2020;11:484.
- Bredeson S, Papaconstantinou J, Deford JH, Kechichian T, Syed TA, Saade GR, et al. HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes. PLoS One. 2014;9(12):e113799.
- Yan H, Zhu L, Zhang Z, Li H, Li P, Wang Y, et al. HMGB1-RAGE signaling pathway in pPROM. Taiwan J Obstet Gynecol. 2018;57(2):211–6.
- Menon R, Behnia F, Polettini J, Saade GR, Campisi J, Velarde M. Placental membrane aging and HMGB1 signaling associated with human parturition. Aging (Albany NY). 2016;8(2):216–30.
- Chavez FG, Correa D, Navarrete-Meneses P, Cancino-Diaz JC, Cancino-Diaz ME, Rodrıguez-Martinez S. NF-kB and its regulators during pregnancy. Front Immunol. 2021;12:679106.
- Romero R, Chaiworapongsa T, Savasa ZA, Xu Y, Hussein Y, Dong Z, et al. Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med. 2011;24(12):1444–55.
- Sheller-Miller S, Urrabaz-Garza R, Saade G, Menon R. Damage-associated molecular pattern markers HMGB1 and cell free fetal telomere fragments in oxidative-stressed amnion epithelial cell-derived exosomes. J Reprod Immunol. 2017;123:3–11.
- Padron JG, Reis CAS, Kendal-Wright CE. The role of danger associated molecular patterns in human fetal membrane weakening. Front Physiol. 2020;11(602).
- Davalos AR, Kawahara M, Malhotra GK, Schaum N, Huang J, Ved U, et al. p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol. 2013;201(4):613–29.
- He Z-W, Qin Y-H, Wang Z-W, Chen Y, Shen Q, Dai S-M. HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF-κB signaling pathways. Mediators Inflamm. 2013;2013:596716.
- Lim S, MacIntyre DA, Lee YS, Khanjani S, Terzidou V, Teoh TG, et al. Nuclear factor kappa B activation occurs in the amnion prior to labour onset and modulates the expression of numerous labour associated genes. PLoS One. 2012;7(4):e34707.
- Wang F, Wang Y, Wang R, Qiu H, Chen L. Predictive value of maternal serum NF-κB p65 and sTREM-1 for subclinical chorioamnionitis in premature rupture of membranes. Am J Reprod Immunol. 2016;76(3):217–23.
- Erşahin SS. The comparison of amniotic fluid nuclear factor-kappa B levels in pregnant women who underwent cesarean section or normal vaginal labor. Perinat J. 2021;29(1):8–12.
- Strauss JF 3rd. Extracellular matrix dynamics and fetal membrane rupture. Reprod Sci. 2013;20(2):140–53.
- Zenerino C, Nuzzo AM, Giuffrida D, Biolcati M, Zicari A, Todros T, et al. The HMGB1/RAGE pro-inflammatory axis in the human placenta: modulating effect of low molecular weight heparin. Molecules. 2017;22(11):1997.
- Liang W-J, Yang H-W, Liu H-N, Qian W, Chen X-L. HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy. Life Sci. 2020;241:117146.
- Mogami H, Kishore AH, Akgul Y, Word RA. Healing of preterm ruptured fetal membranes. Sci Rep. 2017;7(1):13139.
- Fan H, Tang H-B, Chen Z, Wang H-Q, Zhang L, Jiang Y, et al. Inhibiting HMGB1-RAGE axis prevents pro_inflammatory macrophages/microglia polarization and affords neuroprotection after spinal cord injury. J Neuroinflammation. 2020;17(1):295.
- Hazlett LD, McClellan S, Somayajulu M, Bessert D. Targeting inflammation driven by HMGB1 in bacterial keratitis—a review. Pathogens. 2021;10(10):1235.
- Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther. 2020;5(1):209.
Downloads
Published
Issue
Section
License
- Authors retain copyright and grant Althea Medical Journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in Althea Medical Journal. Althea Medical Journal is licensed under CC BY-NC 4.0
- Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Althea Medical Journal.